Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001827506-25-000098
Filing Date
2025-08-13
Accepted
2025-08-13 07:35:13
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q trml-20250630.htm   iXBRL 10-Q 1279904
2 EX-10.1 a06302025exhibit101.htm EX-10.1 15665
3 EX-31.1 a06302025exhibit311.htm EX-31.1 9400
4 EX-31.2 a06302025exhibit312.htm EX-31.2 9694
5 EX-32.1 a06302025exhibit321.htm EX-32.1 7536
11 image.jpg GRAPHIC 29773
  Complete submission text file 0001827506-25-000098.txt   5769081

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT trml-20250630.xsd EX-101.SCH 31186
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT trml-20250630_cal.xml EX-101.CAL 47186
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT trml-20250630_def.xml EX-101.DEF 170643
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT trml-20250630_lab.xml EX-101.LAB 507977
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT trml-20250630_pre.xml EX-101.PRE 349217
63 EXTRACTED XBRL INSTANCE DOCUMENT trml-20250630_htm.xml XML 701291
Mailing Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010
Business Address 27 WEST 24TH STREET SUITE 702 NEW YORK NY 10010 646-481-9832
Tourmaline Bio, Inc. (Filer) CIK: 0001827506 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40384 | Film No.: 251209005
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)